Results 161 to 170 of about 15,524,849 (357)
In this chapter, we have defined an overview of software architecture design. We have focused on three basic topics including software architecture modeling, software architecture design methods, and software architecture evaluation. Software architecture modeling has evolved from informal box and line drawings to extensive architecture frameworks that
openaire +2 more sources
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Proposals for enhancement of the Ada programming language : a software engineering perspective
Mats Weber
openalex +2 more sources
popart: full‐feature software for haplotype network construction
Jessica W. Leigh, D. Bryant
semanticscholar +1 more source
Detecting the number of clusters of individuals using the software structure: a simulation study
G. Evanno, S. Regnaut, J. Goudet
semanticscholar +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Neue Software-Werkzeuge zur Dokumentation der Fragebogenentwicklung [PDF]
Rainer Schnell, Frauke Kreuter
openalex

